
- Article published at:
- Article author: Shahram Lavasani
- Article comments count: 0
Drawer menu
What an incredible experience to be selected to present our innovation in microbiome therapeutics and precision probiotics to His Royal Highness Prince Daniel! Alongside a distinguished delegation from Prince Daniel’s Fellowship and the Royal Swedish Academy of Engineering Sciences (IVA), including Håkan Buskhe, CEO of FAM (Wallenberg Foundations), we had the opportunity to share the groundbreaking work happening at ImmuneBiotech.
It was truly an honour to showcase ImmuneBiotech’s journey—from an ambitious research idea to a globally recognised science-based microbiome innovation. This visit not only validated our work, but also underscored the growing recognition of microbiome therapeutics as a transformative field in healthcare.
During our presentation, we highlighted what makes our precision probiotic, GutMagnific, stand apart in the industry. All probiotics are not the same, and here’s why our approach is unique:
✅ Developed from healthy food-derived strains, rather than traditional sources.
✅ Backed by clinical studies and real-world data, demonstrating effectiveness across diverse customer profiles.
✅ Trusted by leading clinical experts in Europe and the US, further establishing credibility within the medical community.
The discussions with Prince Daniel and the delegation were incredibly inspiring. Their keen interest in microbiome research is a clear signal that this field is gaining the attention it deserves in Sweden. Their support for Swedish innovation and healthcare startups like ours is invaluable.
For over two decades, ImmuneBiotech has pushed the boundaries of probiotic research. By diving deep into the complex interplay between the microbiome, immune system, and gut barrier, we have developed a profound understanding of how these factors influence overall health and well-being. Our research has focused on the underlying mechanisms of gut health and inflammation, allowing us to identify key elements essential for a well-functioning body.
Unlike traditional probiotics, GutMagnific is specifically designed to address complex conditions through a holistic and targeted approach. This science-driven probiotic formulation works to:
The world of biotech startups is fast-paced, full of challenges and breakthroughs. But moments like this—when our work is recognized by leading figures in business and science—reaffirm that we are on the right path.
The momentum is building. The future of microbiome therapeutics is here. And we are proud to be leading the way.